Very severely obese patients have a high prevalence of type 2 diabetes mellitus and cardiovascular disease.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-5233 (Electronic) Linking ISSN: 09405429 NLM ISO Abbreviation: Acta Diabetol Subsets: MEDLINE

Publication: Berlin : Springer Verlag
Original Publication: Berlin : Springer International, c1991-

Cardiovascular Diseases/*epidemiology ; Diabetes Mellitus, Type 2/*epidemiology ; Glucose Intolerance/*epidemiology ; Metabolic Syndrome/*epidemiology ; Obesity, Morbid/*epidemiology; Adult ; Age of Onset ; Blood Glucose/metabolism ; Body Mass Index ; Cardiovascular Diseases/metabolism ; Diabetes Mellitus, Type 2/metabolism ; Fasting ; Female ; Glucose Intolerance/metabolism ; Humans ; Insulin Resistance ; Male ; Metabolic Syndrome/metabolism ; Middle Aged ; Obesity, Morbid/metabolism ; Prevalence ; Risk Factors ; Severity of Illness Index ; Sex Distribution

The prevalence of very severe obesity has increased progressively and faster than other classes of obesity over the last years. It is unclear whether the prevalence of obesity-related complications and health risks increases progressively or reaches a plateau above a certain degree of obesity. The aim of our study was to investigate whether the severity of obesity was correlated with the prevalence of type 2 diabetes mellitus (T2DM), impaired fasting glucose, impaired glucose tolerance (IGT), metabolic syndrome (MS), and cardiovascular diseases (CVDs) in a large cohort of patients with different degrees of obesity. A cross-sectional study was conducted in 938 obese patients without a previous diagnosis of diabetes. Patients were assigned to different categories of obesity: mild-moderate obesity (BMI 30-39.9 kg/m(2)), morbid obesity (BMI 40-49.9 kg/m(2)), and super-obesity (SO, BMI ≥50 kg/m(2)). The prevalence of IGF, IGT, screen-detected T2DM, MS, and CVD was higher in SO patients than in the other groups. Interestingly, the association between SO and either MS or CVD was independent of glucose tolerance status, indicating that factors other than glucose metabolism also favor cardio-metabolic complications in obese patients. In patients without screen-detected T2DM (n = 807), insulin sensitivity and secretion OGTT-derived indexes indicated that SO patients had the worst glucose homeostasis relative to the other categories of obesity, which was indicated by the most reduced disposition index in these patients, a predictor of future T2DM. In conclusion, SO patients have an extremely high prevalence of glucose metabolism deterioration, and cardio-metabolic complications are more prevalent in these patients compared to less obese patients.

0 (Blood Glucose)

Date Created: 20130301 Date Completed: 20131029 Latest Revision: 20220408

20221213

10.1007/s00592-013-0460-3

23447004